Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neuronetics, Inc. - Common Stock
(NQ:
STIM
)
1.885
-0.065 (-3.33%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuronetics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
↗
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Neuronetics's Return On Capital Employed Overview
↗
March 09, 2023
Via
Benzinga
Preview: Neuronetics's Earnings
↗
March 06, 2023
Via
Benzinga
Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
March 02, 2023
United HealthCare Optum Reduces Barriers to TMS Eligibility for Depression Patients
From
Neuronetics
Via
GlobeNewswire
Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS
↗
January 19, 2023
Via
Benzinga
Neuronetics's Return On Capital Employed Overview
↗
December 06, 2022
Via
Benzinga
Short Volatility Alert: Neuronetics, Inc.
↗
October 21, 2022
On Thursday, shares of Neuronetics, Inc. (NASDAQ: STIM) experienced volatile short activity. After the activity, the stock price went down -1.74% to $2.83. The overall sentiment for STIM has been...
Via
Benzinga
Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform
February 23, 2023
Company Launches a New Educational Campaign For Providers
From
Neuronetics
Via
GlobeNewswire
Neuronetics Sponsors the 5th International Brain Stimulation Conference
February 21, 2023
Poster Session Highlights the Strong Dose-Response Relationship and the Importance of Treating Beyond 30 Treatments With NeuroStar Advanced Therapy
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer
February 16, 2023
New Senior Leadership Role Will Streamline Alignment of All Company Revenue-Generating Functions
From
Neuronetics
Via
GlobeNewswire
Short Volatility Alert: Neuronetics, Inc.
↗
September 23, 2022
On Thursday, shares of Neuronetics, Inc. (NASDAQ: STIM) experienced volatile short activity. After the activity, the stock price went up +0.76% to $2.65. The overall sentiment for STIM has been...
Via
Benzinga
Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners
February 10, 2023
NGS MAC Allows Non-Physician Practitioners with Autonomy to Prescribe TMS
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health
January 17, 2023
Peer-reviewed publication shows NeuroStar TMS as an effective non-drug treatment for depression with comorbid anxiety
From
Neuronetics
Via
GlobeNewswire
Despite Competition This Analyst Finds BrainsWay Attractive
↗
August 11, 2022
Via
Benzinga
Recap: Neuronetics Q2 Earnings
↗
August 02, 2022
Neuronetics (NASDAQ:STIM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay
↗
January 10, 2023
Via
Benzinga
Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category
December 05, 2022
NeuroStar’s technology once again recognized as an effective non-drug treatment for patients
From
Neuronetics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
December 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 01, 2022
During Thursday's session, 108 stocks hit new 52-week highs.
Via
Benzinga
Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations
November 14, 2022
Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announced as Winner by 2022 Merit Awards for Technology
October 31, 2022
NeuroStar technology is acknowledged for its innovation and accessibility as a non-drug treatment for mental health
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health
October 25, 2022
Published and Proposed Medicare Coverage through CGS and NGS MACs Will Reduce Number of Medication Trials, Leading to Increased Eligibility for TMS
From
Neuronetics
Via
GlobeNewswire
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
↗
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 27, 2022
Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.
Via
Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
↗
September 28, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 19, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 09, 2022
Via
Benzinga
Earnings Scheduled For August 2, 2022
↗
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
